- Home
- IMMR vs AQST Comparison
IMMR vs AQST Comparison
Compare IMMR & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMR
- AQST
- Stock Information
- Founded
- IMMR 1993
- AQST 2004
- Country
- IMMR United States
- AQST United States
- Employees
- IMMR N/A
- AQST N/A
- Industry
- IMMR Computer peripheral equipment
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- IMMR Technology
- AQST Health Care
- Exchange
- IMMR Nasdaq
- AQST Nasdaq
- Market Cap
- IMMR 237.6M
- AQST 274.4M
- IPO Year
- IMMR 1999
- AQST 2018
- Fundamental
- Price
- IMMR $7.59
- AQST $3.04
- Analyst Decision
- IMMR Strong Buy
- AQST Strong Buy
- Analyst Count
- IMMR 2
- AQST 6
- Target Price
- IMMR $12.25
- AQST $11.17
- AVG Volume (30 Days)
- IMMR 440.1K
- AQST 1.4M
- Earning Date
- IMMR 03-12-2025
- AQST 05-06-2025
- Dividend Yield
- IMMR 5.01%
- AQST N/A
- EPS Growth
- IMMR 57.07
- AQST N/A
- EPS
- IMMR 2.04
- AQST N/A
- Revenue
- IMMR $163,133,000.00
- AQST $57,561,000.00
- Revenue This Year
- IMMR $988.71
- AQST N/A
- Revenue Next Year
- IMMR $288.32
- AQST $39.51
- P/E Ratio
- IMMR $3.71
- AQST N/A
- Revenue Growth
- IMMR 338.21
- AQST 13.79
- 52 Week Low
- IMMR $7.06
- AQST $2.24
- 52 Week High
- IMMR $13.94
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- IMMR 43.85
- AQST 51.97
- Support Level
- IMMR $7.49
- AQST $3.05
- Resistance Level
- IMMR $8.11
- AQST $3.24
- Average True Range (ATR)
- IMMR 0.23
- AQST 0.19
- MACD
- IMMR 0.02
- AQST 0.01
- Stochastic Oscillator
- IMMR 31.58
- AQST 48.53
About IMMR Immersion Corporation
Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.